Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Cancer incidence in the East Azerbaijan province of Iran in 2015-2016: results of a population-based cancer registry.

Somi MH, Dolatkhah R, Sepahi S, Belalzadeh M, Sharbafi J, Abdollahi L, Nahvijou A, Nemati S, Malekzadeh R, Zendehdel K.

BMC Public Health. 2018 Nov 19;18(1):1266. doi: 10.1186/s12889-018-6119-9.

2.

Anti-neoplastic effects of aprotinin on human breast cancer cell lines: In vitro study.

Soleyman-Jahi S, Sadeghi F, Afshari Z, Barati T, Ghasemi S, Muhammadnejad S, Amanpour S, Zendehdel K.

Adv Clin Exp Med. 2019 Feb;28(2):151-157. doi: 10.17219/acem/89770.

3.

Systematic review of priority setting studies in health research in the Islamic Republic of Iran.

Badakhshan A, Arab M, Rashidian A, Gholipour M, Mohebbi E, Zendehdel K.

East Mediterr Health J. 2018 Oct 10;24(8):753-769. doi: 10.26719/2018.24.8.753.

4.

Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in Iran.

Ansaripour A, Zendehdel K, Tadayon N, Sadeghi F, Uyl-de Groot CA, Redekop WK.

PLoS One. 2018 Oct 1;13(10):e0205079. doi: 10.1371/journal.pone.0205079. eCollection 2018.

5.

Correction: The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor ╬▒ and modulates estrogen-stimulated breast cancer cell proliferation.

Zhu J, Zhao C, Kharman-Biz A, Zhuang T, Jonsson P, Liang N, Williams C, Lin CY, Qiao Y, Zendehdel K, Str├Âmblad S, Treuter E, Dahlman-Wright K.

Oncogene. 2019 Jan;38(2):299-300. doi: 10.1038/s41388-018-0502-y.

PMID:
30262864
6.

Development of a tool for comprehensive evaluation of population-based cancer registries.

Sheikhtaheri A, Nahvijou A, Sedighi Z, Hadji M, Golmahi M, Roshandel G, Beiki O, Ravankhah Z, Zendehdel K.

Int J Med Inform. 2018 Sep;117:26-32. doi: 10.1016/j.ijmedinf.2018.06.006. Epub 2018 Jun 10.

PMID:
30032962
7.

Priority-setting in health research in Iran: a qualitative study on barriers and facilitators.

Badakhshan A, Arab M, Rashidian A, Mehrdad N, Zendehdel K.

Health Res Policy Syst. 2018 Jul 2;16(1):57. doi: 10.1186/s12961-018-0313-1.

8.

Response shift in quality of life assessment among cancer patients: A study from Iran.

Hosseini B, Nedjat S, Zendehdel K, Majdzadeh R, Nourmohammadi A, Montazer A.

Med J Islam Repub Iran. 2017 Dec 22;31:120. doi: 10.14196/mjiri.31.120. eCollection 2017.

9.

Economic burden of colorectal cancer in Iran in 2012.

Vahdatimanesh Z, Zendehdel K, Kbari Sari AA, Farhan F, Nahvijou A, Delavari A, Daroudi R.

Med J Islam Repub Iran. 2017 Dec 20;31:115. doi: 10.14196/mjiri.31.115. eCollection 2017.

10.

Epidemiology and Hospitalization Cost of Bladder Cancer in Kerman Province, Southeastern Iran.

Rashidian H, Zendehdel K, Daroudi R, Ebadzadeh MR, Haghdoost AA.

Iran J Public Health. 2018 Apr;47(4):567-574.

11.

The prognostic value of lymph node ratio in survival of head-and-neck squamous cell carcinoma.

Eshraghi Samani R, Shirkhoda M, Hadji M, Beheshtifard F, Hamedani SMMG, Momen A, Mollashahi M, Zendehdel K.

J Res Med Sci. 2018 Apr 26;23:35. doi: 10.4103/jrms.JRMS_948_17. eCollection 2018.

12.

Expression of the three components of linear ubiquitin assembly complex in breast cancer.

Kharman-Biz A, Gao H, Ghiasvand R, Haldosen LA, Zendehdel K.

PLoS One. 2018 May 15;13(5):e0197183. doi: 10.1371/journal.pone.0197183. eCollection 2018.

13.

Design a Fuzzy Rule-based Expert System to Aid Earlier Diagnosis of Gastric Cancer.

Safdari R, Arpanahi HK, Langarizadeh M, Ghazisaiedi M, Dargahi H, Zendehdel K.

Acta Inform Med. 2018;26(1):19-23. doi: 10.5455/aim.2018.26.19-23.

14.

Diseases and Health Outcomes Registry Systems in I.R. Iran: Successful Initiative to Improve Public Health Programs, Quality of Care, and Biomedical Research.

Mojarrab S, Rafei A, Akhondzadeh S, Jeddian A, Jafarpour M, Zendehdel K.

Arch Iran Med. 2017 Nov 1;20(11):696-703.

15.

Correction: Sensitivity of self-reported opioid use in case-control studies: Healthy individuals versus hospitalized patients.

Rashidian H, Hadji M, Marzban M, Gholipour M, Rahimi-Movaghar A, Kamangar F, Malekzadeh R, Weiderpass E, Rezaianzadeh A, Moradi A, Babhadi-Ashar N, Ghiasvand R, Khavari-Daneshvar H, Haghdoost AA, Zendehdel K.

PLoS One. 2018 Feb 8;13(2):e0192814. doi: 10.1371/journal.pone.0192814. eCollection 2018.

16.

Underestimation of cancer incidence in Iran and necessity for establishing population-based cancer registries.

Zendehdel K, Mohebbi E, Malekzadeh R.

Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12754. No abstract available.

PMID:
29372623
17.

Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder.

Afsharpad M, Nowroozi MR, Mobasheri MB, Ayati M, Nekoohesh L, Saffari M, Zendehdel K, Modarressi MH.

Pathol Oncol Res. 2019 Jan;25(1):191-199. doi: 10.1007/s12253-017-0313-4. Epub 2017 Oct 20.

PMID:
29058301
18.

ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma

Afsharpad M, Nowroozi MR, Ayati M, Saffari M, Nemati S, Mohebbi E, Nekoohesh L, Zendehdel K, Modarressi MH.

Iran Biomed J. 2018 May 1;22(3):160-70. Epub 2017 Sep 3.

19.

Sensitivity of self-reported opioid use in case-control studies: Healthy individuals versus hospitalized patients.

Rashidian H, Hadji M, Marzban M, Gholipour M, Rahimi-Movaghar A, Kamangar F, Malekzadeh R, Weiderpass E, Rezaianzadeh A, Moradi A, Babhadi-Ashar N, Ghiasvand R, Khavari-Daneshvar H, Haghdoost AA, Zendehdel K.

PLoS One. 2017 Aug 30;12(8):e0183017. doi: 10.1371/journal.pone.0183017. eCollection 2017. Erratum in: PLoS One. 2018 Feb 8;13(2):e0192814.

20.

Feasibility and Data Quality of the National Spinal Cord Injury Registry of Iran (NSCIR-IR): A Pilot Study.

Naghdi K, Azadmanjir Z, Saadat S, Abedi A, Koohi Habibi S, Derakhshan P, Safdarian M, Abdollah Zadegan S, Amirjamshidi A, Sharif-Alhoseini M, Arab Kheradmand J, Mohammadzadeh M, Zendehdel K, Khazaeipour Z, Hashemi SMR, Saberi H, Karimi Yarandi K, Ketabchi SE, Yousefzadeh-Chabok S, Heidari H, Sotodeh A, Pestei K, Ghodsi Z, Sadeghian F, Noonan V, Benzel EC, Oreilly G, Chapman J, Hagen EM, Fehlings MG, Vaccaro AR, Faghih Jooybari M, Zarei MR, Zafarghandi MR, Salamati P, Nezareh S, Khormali M, Sadeghi-Naini M, Jazayeri SB, Aarabi B, Rahimi-Movaghar V.

Arch Iran Med. 2017 Aug;20(8):494-502.

PMID:
28846013
21.

Systematic Review of Hospital Based Cancer Registries (HBCRs): Necessary Tool to Improve Quality of Care in Cancer Patients

Mohammadzadeh Z, Ghazisaeedi M, Nahvijou A, Rostam Niakan Kalhori S, Davoodi S, Zendehdel K.

Asian Pac J Cancer Prev. 2017 Aug 27;18(8):2027-2033.

22.

Association of socioeconomic status with consumption of cigarettes, illicit drugs, and alcohol.

Marzban M, Hadji M, Gholipour M, Rashidian H, Rezaianzadeh A, Hasanzadeh J, Haghdoost AA, Rahimi-Movaghar A, Ghiasvand R, Moradi A, Khavari-Daneshvar H, Weiderpass E, Kamangar F, Zendehdel K.

J Ethn Subst Abuse. 2017 Aug 18:1-10. doi: 10.1080/15332640.2017.1356256. [Epub ahead of print]

PMID:
28820664
23.

An Ecological Study of the Association between Opiate Use and Incidence of Cancers.

Rashidian H, Zendehdel K, Kamangar F, Malekzadeh R, Haghdoost AA.

Addict Health. 2016 Fall;8(4):252-260.

24.

Cigarette and Water-Pipe Use in Iran: Geographical Distribution and Time Trends among the Adult Population; A Pooled Analysis of National STEPS Surveys, 2006-2009.

Nemati S, Rafei A, Freedman ND, Fotouhi A, Asgary F, Zendehdel K.

Arch Iran Med. 2017 May;20(5):295-301. doi: 0172005/AIM.007.

25.

Travel Burden and Clinical Profile of Cancer Patients Admitted to the Cancer Institute of Iran in 2012.

Sadeghi F, Ardestani A, Hadji M, Mohagheghi MA, Kazemian A, Mirzania M, Mahmoodzadeh H, Aghili M, Zendehdel K.

Arch Iran Med. 2017 Mar;20(3):147-152. doi: 0172003/AIM.006.

26.

Association Between Breast Reconstruction Surgery and Quality of Life in Iranian Breast Cancer Patients.

Sinaei F, Zendehdel K, Adili M, Ardestani A, Montazeri A, Mohagheghi MA.

Acta Med Iran. 2017 Jan;55(1):35-41.

27.

Self-reported versus proxy reported quality of life for breast cancer patients in the Islamic Republic of Iran.

Najafi F, Nedjat S, Zendehdel K, Mirzania M, Montazeri A.

East Mediterr Health J. 2017 Feb 1;22(11):786-793.

28.

Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: 3-Year Survival Study.

Soleyman-Jahi S, Abdirad A, Fallah AA, Ghasemi S, Sadeghi F, Heidari R, Mahmoodzadeh H, Zendehdel K.

Clin Transl Gastroenterol. 2017 Jan 5;8(1):e209. doi: 10.1038/ctg.2016.64.

29.

Fasa Registry on Acute Myocardial Infarction (FaRMI): Feasibility Study and Pilot Phase Results.

Bahramali E, Askari A, Zakeri H, Farjam M, Dehghan A, Zendehdel K.

PLoS One. 2016 Dec 1;11(12):e0167579. doi: 10.1371/journal.pone.0167579. eCollection 2016.

30.

Development of the Draft Clinical Guideline on How to Resuscitate Dying Patients in the Iranian Context: A Study Protocol.

Cheraghi MA, Bahramnezhad F, Mehrdad N, Zendehdel K.

Indian J Palliat Care. 2016 Jul-Sep;22(3):335-42. doi: 10.4103/0973-1075.185078.

31.

Research Ethics Education in Post-Graduate Medical Curricula in I.R. Iran.

Nikravanfard N, Khorasanizadeh F, Zendehdel K.

Dev World Bioeth. 2017 Aug;17(2):77-83. doi: 10.1111/dewb.12122. Epub 2016 Aug 16.

PMID:
27527640
32.

Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of oncology department personnel handling anti-neoplastic drugs.

Mahmoodi M, Soleyman-Jahi S, Zendehdel K, Mozdarani H, Azimi C, Farzanfar F, Safari Z, Mohagheghi MA, Khaleghian M, Divsalar K, Asgari E, Rezaei N.

Drug Chem Toxicol. 2017 Apr;40(2):235-240. doi: 10.1080/01480545.2016.1209678. Epub 2016 Jul 27.

PMID:
27461518
33.

Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer.

Nahvijou A, Daroudi R, Tahmasebi M, Amouzegar Hashemi F, Rezaei Hemami M, Akbari Sari A, Barati Marenani A, Zendehdel K.

PLoS One. 2016 Jun 8;11(6):e0156705. doi: 10.1371/journal.pone.0156705. eCollection 2016.

34.

Estimation of the prevalence and direct medical costs of chronic myeloid leukemia in the I.R. of Iran in the era of tyrosine kinase inhibitors.

Daroudi R, Mirzania M, Nikravanfard N, Sadighi S, Sedighi Z, Zendehdel K.

Asia Pac J Clin Oncol. 2017 Oct;13(5):e416-e422. doi: 10.1111/ajco.12470. Epub 2016 Mar 17.

PMID:
26990676
35.

The Economic Burden of Breast Cancer in Iran.

Daroudi R, Akbari Sari A, Nahvijou A, Kalaghchi B, Najafi M, Zendehdel K.

Iran J Public Health. 2015 Sep;44(9):1225-33.

36.

Neoadjuvant Chemotherapy for Locally Advanced Squamous Carcinoma of Oral Cavity: a Pilot Study.

Sadighi S, Keyhani A, Harirchi I, Garajei A, Aghili M, Kazemian A, Motiee Langroudi M, Zendehdel K, Nikparto N.

Acta Med Iran. 2015;53(6):380-6.

37.

Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines.

Mobasheri MB, Shirkoohi R, Zendehdel K, Jahanzad I, Talebi S, Afsharpad M, Modarressi MH.

Tumour Biol. 2015 Sep;36(10):8201-6. doi: 10.1007/s13277-015-3546-4. Epub 2015 May 21.

PMID:
25994570
38.

Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.

Soleyman-Jahi S, Nedjat S, Abdirad A, Hoorshad N, Heidari R, Zendehdel K.

PLoS One. 2015 Apr 28;10(4):e0122316. doi: 10.1371/journal.pone.0122316. eCollection 2014.

39.

Apoptotic and proliferative activity of mouse gastric mucosa following oral administration of fumonisin B1.

Alizadeh AM, Mohammadghasemi F, Zendehdel K, Kamyabi-Moghaddam Z, Tavassoli A, Amini-Najafi F, Khosravi A.

Iran J Basic Med Sci. 2015 Jan;18(1):8-13.

40.

Completeness and underestimation of cancer mortality rate in Iran: a report from Fars Province in southern Iran.

Marzban M, Haghdoost AA, Dortaj E, Bahrampour A, Zendehdel K.

Arch Iran Med. 2015 Mar;18(3):160-6. doi: 0151803/AIM.005.

41.

Priority Setting for Improvement of Cervical Cancer Prevention in Iran.

Majidi A, Ghiasvand R, Hadji M, Nahvijou A, Mousavi AS, Pakgohar M, Khodakarami N, Abedini M, Amouzegar Hashemi F, Rahnamaye Farzami M, Shahsiah R, Sajedinejhad S, Mohagheghi MA, Nadali F, Rashidian A, Weiderpass E, Mogensen O, Zendehdel K.

Int J Health Policy Manag. 2015 Nov 22;5(4):225-32. doi: 10.15171/ijhpm.2015.201.

42.

Attitude of Iranian Medical Oncologists Toward Economic Aspects, and Policy-making in Relation to New Cancer Drugs.

Daroudi R, Mirzania M, Zendehdel K.

Int J Health Policy Manag. 2015 Oct 20;5(2):99-105. doi: 10.15171/ijhpm.2015.186.

43.

Resistance to single-agent chemotherapy and its risk factors in low-risk gestational trophoblastic neoplasms.

Mousavi AS, Zamani A, Khorasanizadeh F, Gilani MM, Zendehdel K.

J Obstet Gynaecol Res. 2015 May;41(5):776-83. doi: 10.1111/jog.12613. Epub 2014 Dec 10.

PMID:
25492546
44.

A systematic review of economic aspects of cervical cancer screening strategies worldwide: discrepancy between economic analysis and policymaking.

Nahvijou A, Hadji M, Marnani AB, Tourang F, Bayat N, Weiderpass E, Daroudi R, Sari AA, Zendehdel K.

Asian Pac J Cancer Prev. 2014;15(19):8229-37. Review.

45.

Management of precancerous cervical lesions in iran: a cost minimizing study.

Nahvijou A, Sari AA, Zendehdel K, Marnani AB.

Asian Pac J Cancer Prev. 2014;15(19):8209-13.

46.

Higher incidence of premenopausal breast cancer in less developed countries; myth or truth?

Ghiasvand R, Adami HO, Harirchi I, Akrami R, Zendehdel K.

BMC Cancer. 2014 May 19;14:343. doi: 10.1186/1471-2407-14-343.

47.

Factors affecting professional delay in diagnosis and treatment of oral cancer in Iran.

Esmaelbeigi F, Hadji M, Harirchi I, Omranipour R, vand Rajabpour M, Zendehdel K.

Arch Iran Med. 2014 Apr;17(4):253-7. doi: 014174/AIM.007.

48.

Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.

Barfar E, Rashidian A, Hosseini H, Nosratnejad S, Barooti E, Zendehdel K.

Arch Iran Med. 2014 Apr;17(4):241-5. doi: 014174/AIM.005.

49.

Situation analysis of the National Comprehensive Cancer Control Program (2013) in the I. R. of Iran; assessment and recommendations based on the IAEA imPACT mission.

Rouhollahi MR, Mohagheghi MA, Mohammadrezai N, Ghiasvand R, Ghanbari Motlagh A, Harirchi I, Zendehdel K.

Arch Iran Med. 2014 Apr;17(4):222-31. doi: 014174/AIM.003.

50.

In vitro assessment of antineoplastic effects of deuterium depleted water.

Soleyman-Jahi S, Zendehdel K, Akbarzadeh K, Haddadi M, Amanpour S, Muhammadnejad S.

Asian Pac J Cancer Prev. 2014;15(5):2179-83.

Supplemental Content

Loading ...
Support Center